News & Announcements

Johns Hopkins neuroscientists show how specialized cells signal the presence of light simultaneously in two distinct ways Working with mammalian retinal cells, neuroscientists at Johns

Letter of Intent Deadline: Friday, February 9, 2024 Application Deadline: Friday, March 1, 2024   The Fisher Center for Environmental Infectious Diseases, through the continued

  Credit: Adobe Stock Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death,

Getty Images Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward

Teneurin-3 appears to help wire the brain in mice to resist changes in sleep and other cycles linked to changing light Credit: Getty Images Scientists

Congratulations to the 2023 Team Science Awardees! We are pleased to announce the 2023 recipients of the Johns Hopkins Institute for Clinical and Translational Research

Findings focus on alpha-synuclein and its role in killing brain cells Second row shows how rapamycin dampens alpha-synuclein protein production in a magnified area of

Findings seen as a step toward ending need for invasive kidney biopsies to predict AKI, and to help manage and assess treatment of serious kidney

The Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple investigators

This article discusses the work of Barbara Slusher, PhD, MAS, director of Johns Hopkins Drug Discovery, and co-leader of the ICTR Drug, Biologics, Vaccines and Devices Translational Research Community.

Article courtesy of the NIH A monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume without

Using a “liquid biopsy” to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with

Comparing PET scans of more than 90 adults with and without mild cognitive impairment (MCI), Johns Hopkins Medicine researchers say relatively lower levels of the